EGFR and squamous cell carcinoma: Additionally, LIPTAC1 efficiently degraded EGFR with a maximal percent degradation (Dmax) of 86%, on the EGFR high expressing epidermoid carcinoma cell line A431 (Fig. 2e,2f).